The Mitotic Activity Index in combination with Her2neu: a strong prognosticator in breast cancer. Jobsen JJ, Struikmans H, van der Palen J, Siemerink E, et al. Breast Cancer Res Treat 2020 Mar 30. pii: 10.1007/s10549-020-05610.

Read + Share

Amedeo Smart

Independent Medical Education

Jobsen JJ, Struikmans H, van der Palen J, Siemerink E, et al. The Mitotic Activity Index in combination with Her2neu: a strong prognosticator in breast cancer. Breast Cancer Res Treat 2020 Mar 30. pii: 10.1007/s10549-020-05610.
PMID: 32232697